PricewaterhouseCoopers

• 

  PwC survey identifies RMORSA preparedness gap

  By Warren S. Hersch  |  January 23, 2013

  Less than 40 percent of company boards are not engaged or are only passively engaged in risk management.

• 

  PwC Survey: Drug Manufacturers Must Demonstrate Clinical, Economic Benefits of Products

  By Warren S. Hersch  |  May 17, 2012

  A shift in consumer and provider preferences could hurt revenues for drug manufacturers that don’t speed efforts to demonstrate the clinical and economic benefits of their products, according to a new PricewaterhouseCoopers survey.

• 

  PwC: Three in Four Insurers Expect Changes to Risk Management Strategies

  By Warren S. Hersch  |  March 28, 2012

  Approximately 75% of insurers anticipate changing the way they manage risk and nearly 40% plan to modify their capital structure over the next 12 months, new research reveals.